1. Executive Overview

GSP Crop Science Limited, incorporated in 1985, is a research-driven agrochemical company focused on crop protection products like insecticides, herbicides, fungicides, and plant growth regulators. With over 40 years of experience, the company operates through two key segments—Formulations (ready-to-use products) and Technicals (active ingredients). It has evolved into a strong player in the Indian agriculture sector with a focus on innovation and product development.

The company operates five manufacturing units across Gujarat and Jammu & Kashmir, with large production capacity and a strong regulatory base (500+ registrations and 100+ patents). It earns over 90% of its revenue from India while exporting to 37 countries. Its strengths include in-house R&D, backward integration, and long-term relationships with industry players, helping it maintain stable growth and margins (~16% EBITDA in H1 FY26).

2. Business Model and Revenue Streams

GSP Crop Science operates a hybrid business model targeting both B2B (Business-to-Business) and B2C (Business-to-Customer) segments. In the Domestic Business, the company sells Technicals and Formulations to other agrochemical corporates (B2B) and branded formulations directly to a network of 4,801 distributors (B2C) as of September 30, 2025. The International Business is primarily B2B, focusing on 37 global markets including Brazil, USA, and Australia.

Revenue Breakdown by Business Segment

The following table summarizes the revenue contribution from the two core business lines:

Key Operating Metrics

• Customer Concentration: The company maintains a diversified base, with the Top 10 customers accounting for only 22.87% of revenue in H1 FY26, down from 32.70% in FY 2023.
• Patented Revenue: Revenue from patented products contributed ₹1,436.75 million (17.10%) to the total sale of products in H1 FY26.
• Geographic Focus: Gujarat remains the largest domestic market, contributing 27.27% of total revenue in H1 FY26, followed by Maharashtra (16.91%).
• Working Capital: The company managed a Net Working Capital cycle of 110 days as of September 30, 2025.

3. Products and Service Portfolio

The company’s portfolio is diversified across four major agricultural categories, primarily focused on protecting Rice, Wheat, Groundnut, and Chilli crops.

Product Category Performance (H1 FY26):

• Insecticides: The primary revenue driver, contributing ₹4,940.30 million (58.79%). Key brands include SLR 525, Raavan, and Liger.
• Herbicides: Contributed ₹1,251.35 million (14.89%). Key brands include Platform and Pendi Rich.
• Fungicides: Contributed ₹1,283.72 million (15.28%). Key brands include Dronex and Element.
• PGRs and Others: Contributed ₹928.44 million (11.05%). Key brand includes Flute.

Operational Infrastructure and Capacity:

4. Key Business Strengths

• Diversified Product Portfolio: Offers a comprehensive range of 524 registrations across insecticides, herbicides, and fungicides.
• Strong R&D and Intellectual Property: Holds 102 granted patents and a dedicated team of 35 R&D professionals, including 5 PhD holders.
• Proven Track Record of Innovation: Among the first indigenous manufacturers to secure exclusive patents for formulations like Platform and Raavan.
• Extensive Sales Network: Reaches the Indian retail market through a robust network of 4,801 active distributors as of September 2025.
• Robust Manufacturing and Sustainability: Operates five specialized facilities with integrated Effluent Treatment Plants (450 KL) and ISO certifications.
• Experienced Management: Led by Promoters with 40+ years of industry experience and a professional workforce of 1,221 permanent employees.

5. Future Growth Strategy

• International Market Expansion: Aggressively expanding into Brazil and Uruguay to capitalize on the high-growth Latin American agrochemical market.
• Backward Integration Focus: Increasing production of Intermediates at the Saykha facility to reduce import dependency and improve gross margins.
• Portfolio Diversification: Continuing to register and launch new off-patent molecules and patented unique formulations to increase wallet share.
• De-leveraging the Balance Sheet: Utilizing IPO proceeds (₹1,700 million) to repay high-cost borrowings and improve the Net Debt to Equity ratio.
• Deepening B2C Presence: Strengthening the pan-India distribution network to enhance direct brand visibility among farmers.
• Technological Advancement: Leveraging pilot plant facilities to accelerate the commercialization of complex chemistries and chiral inductions.